Physician profile
Kevin Robert Murray
NPI 1740361575
$808.17
in general payments reported to CMS, 2019-2025
12 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $15.54 · 2021: $11.98 · 2022: $103 · 2023: $49.49 · 2024: $137 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $186.35 | 2019-2024 | Fms Duo, Gryphon Orthocord |
| Stryker Corporation | $161.75 | 2019 | |
| Electronic Waveform Lab, INC. | $136.10 | 2019-2025 | |
| Smith+Nephew, INC. | $120.82 | 2019 | |
| Medtronic, INC. | $84.55 | 2022 | |
| Fidia Pharma USA INC. | $29.49 | 2019-2020 | |
| Orthofix Medical, INC. | $18.64 | 2022 | |
| Masimo Corporation | $16.46 | 2023 | Patient Safetynet System |
| Trevena, INC. | $16.17 | 2023 | Olinvyk |
| Bioventus LLC | $13.40 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.46 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.